Virion Biotherapeutics
New therapeutic modality designed to transform patient care for respiratory virus diseases
Virion’s mission is a developer of biological antivirals creates to offer improved therapeutics for respiratory viral infections. The company's antivirals focus on prevention and treatment of influenza and respiratory syncytial virus (RSV), enabling doctors to get a broad-spectrum therapy for respiratory viral infections, potentially
simplifying and accelerating treatment by removing the need for differential diagnosis.
Details last updated 03-Oct-2019